PT1800664E - Formulações farmacêuticas para administração parentérica compreendendo epotilona - Google Patents

Formulações farmacêuticas para administração parentérica compreendendo epotilona Download PDF

Info

Publication number
PT1800664E
PT1800664E PT07102856T PT07102856T PT1800664E PT 1800664 E PT1800664 E PT 1800664E PT 07102856 T PT07102856 T PT 07102856T PT 07102856 T PT07102856 T PT 07102856T PT 1800664 E PT1800664 E PT 1800664E
Authority
PT
Portugal
Prior art keywords
epothilone
pharmaceutical formulations
parenteral administration
administration
methods
Prior art date
Application number
PT07102856T
Other languages
English (en)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1800664(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1800664E publication Critical patent/PT1800664E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT07102856T 1998-02-05 1999-02-03 Formulações farmacêuticas para administração parentérica compreendendo epotilona PT1800664E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds

Publications (1)

Publication Number Publication Date
PT1800664E true PT1800664E (pt) 2009-07-10

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07102856T PT1800664E (pt) 1998-02-05 1999-02-03 Formulações farmacêuticas para administração parentérica compreendendo epotilona

Country Status (9)

Country Link
EP (1) EP1800664B8 (pt)
AT (1) ATE427736T1 (pt)
CY (1) CY1109190T1 (pt)
DE (1) DE69940708D1 (pt)
DK (1) DK1800664T3 (pt)
ES (1) ES2324376T3 (pt)
GB (1) GB9802451D0 (pt)
PT (1) PT1800664E (pt)
ZA (1) ZA99874B (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
ES2178093T5 (es) * 1995-11-17 2009-02-16 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Derivados de epotilon y su preparacion.
HU226646B1 (en) * 1996-03-12 2009-05-28 Pg Txl Company Water soluble pharmaceutical compositions containing taxane derivatives
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
MY125921A (en) * 1998-02-05 2006-08-30 Novartis Ag Compositions containing organic compounds

Also Published As

Publication number Publication date
DE69940708D1 (de) 2009-05-20
GB9802451D0 (en) 1998-04-01
EP1800664A1 (en) 2007-06-27
ES2324376T3 (es) 2009-08-05
EP1800664B8 (en) 2010-12-15
EP1800664B1 (en) 2009-04-08
ATE427736T1 (de) 2009-04-15
ZA99874B (en) 1999-08-05
DK1800664T3 (da) 2009-07-20
CY1109190T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
GEP20053473B (en) High Potency Dihydroergotamine Compositions
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
WO2000007979A3 (en) Compounds and compositions for delivering active agents
TW355683B (en) Composition containing micronized nebivolol
HK1036970A1 (en) Compounds and compositions for delivering active agents.
MXPA03002070A (es) Proceso de anticoncepcion y forma de administracion para el mismo.
EP0993831A3 (en) Compounds and compositions for delivering active agents
IL136512A0 (en) Intravenous infusion administration set
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
BG103219A (en) Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2000003724A1 (fr) Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif
ZA97657B (en) Ligand directed enzyme prodrug therapy.
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
PT1800664E (pt) Formulações farmacêuticas para administração parentérica compreendendo epotilona
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
IL139863A0 (en) 3,4-diphenyl bicyclo [4.3.0] nonyl derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen